Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ARTV stock hub

Artiva Biotherapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARTVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

269.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARTV

In the news

Latest news · ARTV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-67.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-41

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARTV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001817241
Company name	Artiva Biotherapeutics, Inc.
Country	United States
Country code	US
Employees	104
Employees Change	15%
Employees Change Percent	16.85
Enterprise value	$192.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-07-19
Isin	US04317A1079
Last refreshed	2026-05-10
Market cap	$269.2M
Market cap category	Micro-Cap
Price	$10.89
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	ARTV
Website	https://www.artivabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-32.35%
FCF yield	-29.79%
P/B ratio	3.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-87.1M
Net Income Growth Years	0%
Profit Per Employee	$-837,212
ROA	-38.72
Roa5y	-26.78
ROCE	-96.84
ROE	-67.86
Roe5y	-62.5
ROIC	-40.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	419.16%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$106M
Cash	$86.8M
Current Assets	$88.7M
Current Liabilities	$10.9M
Debt	$10.3M
Debt Equity	$0.12
Equity	$87.8M
Liabilities	$18.1M
Long Term Assets	$17.2M
Long Term Liabilities	$7.2M
Net Cash	$76.5M
Net Cash By Market Cap	$28.43
Net Cash Growth	-49.65%
Net Debt Equity	$-0.87
Tangible Book Value	$87.8M
Tangible Book Value Per Share	$3.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.16
Net Working Capital	$-5.9M
Quick ratio	7.98
Working Capital	$77.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-43.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	418.57%
200-day SMA	4.72
50-day SMA	7.91
50-day SMA vs 200-day SMA	50over200
All Time High	17.31
All Time High Change	-37.09%
All Time High Date	2024-10-01
All Time Low	1.47
All Time Low Change	640.82%
All Time Low Date	2025-06-27
ATR	1.37
Beta1y	4.67
Beta2y	2.32
Ch YTD	153.8
High	12.68
High52	14.53
High52 Date	2026-04-20
High52ch	-25.05%
Low	10.2
Low52	1.47
Low52 Date	2025-06-27
Low52ch	640.82%
Ma50ch	37.73%
Premarket Change Percent	-3.19
Premarket Price	$12.12
Premarket Volume	1,852,452
Price vs 200-day SMA	130.87%
RSI	55.17
RSI Monthly	54.98
RSI Weekly	68.25
Sharpe ratio	1.56x
Sortino ratio	3.95
Total Return	-43.09%
Tr YTD	153.8
Tr1m	63.27%
Tr1w	0.83%
Tr3m	170.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$20.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.85
Operating Income	$-92.1M
Price target	$25.33
Price Target Change	$133
Price Target Change Top	$88.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,997,386%
Float Percent	24.26%
Net Borrowing	-132,000
Shares Insiders	1.36%
Shares Institutions	13.05%
Shares Out	24,716,672
Shares Qo Q	0.43%
Shares Yo Y	43.09%
Short Float	2.48%
Short Ratio	0.78
Short Shares	0.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.5M
Average Volume	617,723.25x
Bv Per Share	3.55
CAPEX	$-2.3M
Ch1m	63.27
Ch1w	0.83
Ch1y	418.6
Ch3m	170.2
Ch6m	214.7
Change	-13.02%
Change From Open	-9.63
Close	12.52
Days Gap	-3.75
Depreciation Amortization	2,635,000
Dollar Volume	57,649,993.8
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-92.1M
EBITDA	$-89.4M
EPS	$-3.55
F Score	1
FCF	$-80.2M
FCF EV Yield	-41.62x
FCF Per Share	$-3.24
Financing CF	-342,000
Fiscal Year End	December
Founded	2,019
Investing CF	68,756,000
Ipr	-9.25
Iprfo	-31.94
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	5.33
Ma150ch	104.24%
Ma20	10.75
Ma20ch	1.31%
Net CF	-9,446,000
Next Earnings Date	2026-08-05
Open	12.05
Optionable	No
Position In Range	27.82
Post Close	10.89
Postmarket Change Percent	5.6
Postmarket Price	$11.5
Ppne	16,296,000
Pre Close	12.52
Price Date	2026-05-08
Ptbv Ratio	3.06
Relative Volume	8.57x
Share Based Comp	6,362,000
Tr6m	214.74%
Us State	California
Volume	5,293,847

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARTV pay a dividend?

Capital-return profile for this ticker.

Performance

ARTV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARTV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.0%

Float: +24.3% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARTV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.2

Neutral momentum band

Price vs 200-day MA

+130.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARTV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARTV stock rating?

Artiva Biotherapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARTV analysis?

The full report lives at /stocks/ARTV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARTV?

The latest report frames ARTV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARTV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.